another new "glitazone" for type 2 diabetes, Actos (pioglitazone)
August 1999
You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone).
This is the third one...after Rezulin (troglitazone) and Avandia (rosiglitazone).
These drugs lower blood glucose by improving insulin sensitivity.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote